Histological evaluation of hysterectomy specimens after NovaSure® endometrial ablation in patients with atypical endometrial hyperplasia or endometrial carcinoma

Abstract Background Treatment with NovaSure® endometrial ablation is approved for patients with heavy menstrual bleeding (HMB) without evidence of malignant or premalignant lesions. This analysis addresses the rare but clinically relevant situation in which endometrial carcinoma (EC) or atypical hyp...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Oliver M. Schleicher, Alaa Hamzeh, Julia Gocke, Patrik Poeschke, Frederik A. Stuebs, Stefanie Burghaus, Felix Heindl, Arndt Hartmann, Matthias W. Beckmann, Christian Matek, Julius Emons
Format:	Artigo
Jezik:	Inglês
Izdano:	Springer 2026-06-01
Serija:	Archives of Gynecology and Obstetrics
Teme:	NovaSure® endometrial ablation atypical endometrial hyperplasia endometrial carcinoma
Online dostop:	https://doi.org/10.1007/s00404-026-08497-x
Oznake:	Označite Brez oznak, prvi označite!